Find clinical trials for myasthenia gravis. Search for myasthenia gravis clinical trials in different cities and states across the United States.
Myasthenia Gravis is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue, often affecting the eyes, face, swallowing, speech, and breathing muscles. Symptoms may include drooping eyelids, double vision, difficulty speaking, and weakness that worsens with activity. Clinical trials for Myasthenia Gravis explore new therapies aimed at improving muscle function, reducing immune system attacks, and managing symptoms more effectively. Myasthenia Gravis may be connected to conditions like Autoimmune Disorders, Neurological Disorders, Multiple Sclerosis, and Chronic Fatigue — explore related condition trials below.
Filter
1
Filter results
Results: 54
Active & Responsive
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
for
Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis,
Location: Los Altos CA
Sponsor: xCures
Sex: All
Age: 0+
Code: NCT06539169
Recruiting
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Miami FL, Indianapolis IN, Columbia MO,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase2, Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Boston MA, Quebec, Washington D.C. DC, Ottawa,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06744920
Phase3, Recruiting
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Active & Responsive
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
for
Myasthenia Gravis
Location: Lake Success NY, Philadelphia PA, Durham NC,
Sponsor: Ad scientiam
Sex: All
Age: 18+
Code: NCT05564936
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now